SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Strides Pharma Science informs about update to earnings call

18 May 2026 Evaluate

With reference to its intimation dated May 11, 2026, regarding the Earnings Call invite for investors and analysts to discuss the audited financial results of the Company for the quarter and financial year ended March 31, 2026, which is scheduled today, May 18, 2026. Strides Pharma Science has informed that US time for the said Earnings Call is 7:30 am EDT (instead of 6:30 am EST as communicated earlier). Updated timing for Earnings Call scheduled today is ‘5:00 PM IST/ 11:30 AM GMT/ 7:30 AM EDT/ 7:30 PM HKT’.

The above information is a part of company’s filings submitted to BSE.

Strides Pharma Scien Share Price

1054.30 64.95 (6.56%)
12-Jun-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1807.25
Dr. Reddys Lab 1273.90
Cipla 1388.80
Zydus Lifesciences 1104.35
Lupin 2292.70
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: